COVID-19 news

Recommendations from the Australian Technical Advisory Group on Immunisation (ATAGI) on the use of the Moderna bivalent (Original/Omicron BA.4/5) COVID-19 vaccine.

Recommendations from the Australian Technical Advisory Group on Immunisation (ATAGI) on the use of the Pfizer bivalent (Original/Omicron BA.4/5) COVID-19 vaccine.

Recommendations from the Australian Technical Advisory Group on Immunisation (ATAGI) on Pfizer booster doses for children aged 5 to 11 years.

Australia’s immunisation experts, the Australian Technical Advisory Group on Immunisation, recommend COVID-19 vaccination for some children aged 6 months to under 5 years who have an increased risk of getting very sick from COVID-19. The COVID-19 vaccination will help reduce this risk.

A statement from the Australian Technical Advisory Group on Immunisation (ATAGI) regarding COVID-19 Moderna Spikevax Bivalent Original/Omicron BA.1 vaccine.

The Australian Health Protection Principal Committee (AHPPC) notes the need for a proportionate approach to isolation for those with COVID‑19 infections at this stage of the pandemic.

An update from the Australian Technical Advisory Group on Immunisation (ATAGI) following their weekly meeting on 31 August 2022.

The following statement was released following the conclusion of National Cabinet on Wednesday 31 August 2022.

An update from the Australian Technical Advisory Group on Immunisation (ATAGI) following their weekly meeting on 24 August 2022.

Recommendations from the Australian Technical Advisory Group on Immunisation (ATAGI) on the use of the Novavax vaccine for adolescents aged 12-17 years.